您的位置: 首页 > 农业专利 > 详情页

NEW THERAPY FOR TRANSTHYRETIN-ASSOCIATED AMYLOIDOSIS
专利权人:
SOM INNOVATION BIOTECH; S.L.
发明人:
Marc Centellas Casado,Raúl Insa Boronat,Nuria Reig Bolaño,Núria Gavaldà Batalla
申请号:
US14353459
公开号:
US20140296188A1
申请日:
2012.10.23
申请国别(地区):
US
年份:
2014
代理人:
摘要:
It is provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of trans-thyretin-associated amyloidosis. It is also provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis in combination therapy with another COMT inhibitor, a benzoxazole derivative, iododiflunisal, diflunisal, resveratrol, tauroursodeoxycholic acid, doxocycline, or epigallocatechin-3-gallate.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充